Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

American Heart Association In Brief: CardioGenesis

This article was originally published in The Gray Sheet

Executive Summary

CardioGenesis: First human procedure with firm's PMR (percutaneous myocardial revascularization) system is completed at Herzzentrum (Heart Center) Frankfurt AG in Frankfurt, Germany. CardioGenesis' system is designed for use by interventional cardiologists as a minimally invasive method for transmyocardial revascularization ("The Gray Sheet" Aug. 19, I&W-2). The company, which initially is conducting clinical trials overseas, plans to submit an investigational device exemption to FDA in the first half of 1997...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007079

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel